Alivus Life Sciences schedules investor and analyst meetings

Alivus Life Sciences Limited has announced upcoming meetings with investors and analysts, in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The company, through its company secretary and compliance officer, Rudalf Corriea, notified the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) of these engagements scheduled for early December 2025.

On December 04, 2025, Alivus Life Sciences will hold a virtual one-on-one meeting with Kosh Wealth Management. The following day, December 05, 2025, the company is scheduled for an in-person one-on-one meeting with Karma Capital in Mumbai.

The company noted that the schedule and mode of these meetings are subject to change due to unforeseen circumstances. This intimation serves to keep stakeholders informed of the company's investor relations activities.